Interactive modeling for ongoing utility of pharmacogenetic diagnostic testing: application for warfarin therapy.
about
Pharmacogenetics-based warfarin dosing in childrenEffect of genetic variants, especially CYP2C9 and VKORC1, on the pharmacology of warfarinClinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiationGenotype-based dosing algorithms for warfarin therapy: data review and recommendations.A review of a priori regression models for warfarin maintenance dose prediction.Genetics informatics trial (GIFT) of warfarin to prevent deep vein thrombosis (DVT): rationale and study design.Canalization effect in the coagulation cascade and the interindividual variability of oral anticoagulant response. A simulation studyPharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials.Current challenges in personalizing warfarin therapy.Prediction of warfarin dose: why, when and how?Pharmacogenetics of antiplatelets and anticoagulants: a report on clopidogrel, warfarin and dabigatran.Warfarin Dosing Algorithms Underpredict Dose Requirements in Patients Requiring ≥7 mg Daily: A Systematic Review and Meta-analysis.Evaluation of methods for achieving stable INR in healthy subjects during a multiple-dose warfarin study.Warfarin Metabolites in Patients Following Cardiac Valve Implantation: A Contribution of Clinical and Genetic Factors.Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial.Prospective pilot trial of PerMIT versus standard anticoagulation service management of patients initiating oral anticoagulation.Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy.How to use warfarin assays in patient management: analysis of 437 warfarin measurements in a clinical setting.
P2860
Q27008320-0E5D401F-9505-4635-A462-1E5BDF891F1CQ28276514-EC3D01F2-8BC7-4529-94F7-DD862CD86D8FQ31042226-D8E2D1E7-DB60-4BFB-A001-00B1CF1811F7Q34065133-0A985F8D-7D53-46BD-B316-A98109D9F146Q34690708-B9AFA847-EE79-45F1-8E3C-C4F1A7466C43Q35218128-30DB4351-5BC2-47D6-9368-17EB18E90A3BQ35548719-9A8818FF-2A25-454A-806E-F75D16809FF5Q35870028-DD614892-B4A9-4D6B-88C6-D0A972698570Q37960511-8D6DBE65-AAC0-4DE0-B031-CB2B97FED070Q37989489-CC7475D9-78A4-4292-84E4-940222BF77A0Q38148597-360A21E9-FAA8-4DA4-9C90-ACCC791257B8Q38979667-6B7CB6F9-0A2B-4DF8-A9A5-B350CF38A881Q39712065-8B6FD8EE-3AEC-4966-B2DE-969EB2EE24B2Q42701736-1752A143-5918-4162-9E9B-5A28014CCE1DQ48580819-D463047C-1E00-42FC-B137-CFC57895B0D4Q50348713-AF503555-6B83-4F36-AE9A-4D9CB1E67607Q51467614-A33989A7-41C1-4F8D-ACD8-F7B647807C36Q53080284-91783E07-5BB3-40E0-B325-0E992BE1E3B3
P2860
Interactive modeling for ongoing utility of pharmacogenetic diagnostic testing: application for warfarin therapy.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Interactive modeling for ongoi ...... lication for warfarin therapy.
@ast
Interactive modeling for ongoi ...... lication for warfarin therapy.
@en
type
label
Interactive modeling for ongoi ...... lication for warfarin therapy.
@ast
Interactive modeling for ongoi ...... lication for warfarin therapy.
@en
prefLabel
Interactive modeling for ongoi ...... lication for warfarin therapy.
@ast
Interactive modeling for ongoi ...... lication for warfarin therapy.
@en
P2093
P2860
P1433
P1476
Interactive modeling for ongoi ...... lication for warfarin therapy.
@en
P2093
Brian F Gage
Charles Eby
Kristen K Reynolds
Marjorie Bon Homme
Mark W Linder
Natalia Silvestrov
Roland Valdes
P2860
P304
P356
10.1373/CLINCHEM.2009.125898
P407
P577
2009-08-13T00:00:00Z